Tag Archives: NVCR

Top 5 Undervalued Stocks To Own For 2019

Willamette Valley Vineyards (NASDAQ: WVVI) is a nano-cap winery located in Turner, Oregon. The company produces various mid end, premium, and ultra-premium wines including the Pinot Noir, Chardonnay, Pinot Gris, Ros茅 and Riesling varieties. We usually cover tech stocks but we are big fans of wine and even bigger fans of undervalued stocks; WVVI certainly fits the bill for both. WVVI has enjoyed tremendous average sales and EBITDA growth of 12.8% and 16% respectively for the past 3 years. During the same time period, investors have been met with a modest stock growth of 23.75% from $6.10 to $8 currently. With a market cap of only $40 million and a fair P/E of 22, we believe there is still undiscovered potential for this profitable company and its drought-free wine business.

The Economy of Wine

In the past 6 years, United States wine consumption has seen healthy growth from 336.3 million 9 liter cases in 2010 to 383.9 million 9 liter cases in 2015, This resulted in the total retail value of wine increasing from $46.5 billion in 2010 to $55.8 billion in 2015, a significant 20% growth rate. According to a recent report by goodfruits.com, this growth trend continued in 2016 as “September U.S. wine sales rose from $3.3 billion to $3.7 billion, helping set an annual pace to boost the industry’s overall retail value for the 11th consecutive year”. The prior three 5 year periods has seen total retail value increase by 8.8 billion (2001-2005), 5 billion (2006-2010) and 7.2 (2011-2015). We expect the wine market retail value to grow 1.5% (average growth of the last 3 years) in 2017 and surpass $62 billion by 2020. This growth in wine consumption is further fueled by the inauguration of Donald Trump, whose victory has left many oppositions drinking to a stupor. Under these conditions, we believe specialize vineyards like WVVI are going to earn steady and growing profits for years to come.

Top 5 Undervalued Stocks To Own For 2019: Foamix Pharmaceuticals Ltd.(FOMX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Press coverage about Foamix Pharmaceuticals (NASDAQ:FOMX) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Foamix Pharmaceuticals earned a news impact score of 0.14 on Accern’s scale. Accern also assigned press coverage about the specialty pharmaceutical company an impact score of 45.4298608245084 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Top 5 Undervalued Stocks To Own For 2019: PJT Partners Inc.(PJT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on PJT Partners (PJT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Own For 2019: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Novocure (NVCR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Feroldi]

    After the company announced details of its phase 3 INNOVATE-3 trial at theAmerican Society of Clinical Oncology (ASCO) annual meeting, shares ofNovoCure (NASDAQ:NVCR), a red-hot medical device companyfocused on cancer, fell as much as12% in early morning trading today. Shares were down about 10% as of 10:30 a.m. EDT.

  • [By Ethan Ryder]

    NovoCure (NASDAQ:NVCR) Director Gabriel Leung sold 80,000 shares of the firm’s stock in a transaction on Wednesday, May 16th. The stock was sold at an average price of $28.83, for a total value of $2,306,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Chris Lange]

    Novocure Ltd. (NASDAQ: NVCR) announced results from its Phase 3 INNOVATE trial of TTFields in platinum-resistant ovarian cancer. There were no major surprises, except study size is larger than some investors expected, which is not concerning. INNOVATE-3 is set to start later this year and as previously announced will enroll patients with recurrent platinum-resistant ovarian cancer.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NovoCure (NVCR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Undervalued Stocks To Own For 2019: Nektar Therapeutics(NKTR)

Advisors’ Opinion:

  • [By Todd Campbell]

    Surprising and market-moving information often comes out of the annual American Society of Clinical Oncologists (ASCO) meeting, and so far, ASCO18 hasn’t disappointed. From bluebird bio’s (NASDAQ:BLUE) great-but-not-good-enough results in multiple myeloma to Loxo Oncology’s (NASDAQ:LOXO) stellar results in RET-fusion cancers to Nektar Therapeutics (NASDAQ:NKTR) head-scratching data,here are some quick takes on the data released this weekend.

  • [By Stephan Byrd]

    TRADEMARK VIOLATION NOTICE: “Nektar Therapeutics (NKTR) Trading Down 7%” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another site, it was stolen and republished in violation of US & international trademark and copyright law. The original version of this piece of content can be viewed at www.tickerreport.com/banking-finance/3362849/nektar-therapeutics-nktr-trading-down-7.html.

  • [By Ethan Ryder]

    Nektar Therapeutics (NASDAQ:NKTR) has been given a consensus recommendation of “Buy” by the fifteen ratings firms that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $85.09.

Top 5 Undervalued Stocks To Own For 2019: LightPath Technologies, Inc.(LPTH)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results.
    LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat.
    MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results.
    Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat.
    Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday.
    Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday.
    PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results.
    Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy.
    Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat.
    Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Joseph Griffin]

    Headlines about LightPath Technologies (NASDAQ:LPTH) have been trending somewhat positive on Monday, Accern Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. LightPath Technologies earned a daily sentiment score of 0.14 on Accern’s scale. Accern also assigned press coverage about the technology company an impact score of 46.9867601112654 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Best Medical Stocks To Invest In Right Now

Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance, it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.

Click the Company Name links in the tables below to analyze a company’s or insider’s full insider history.

Educational note from InsiderInsights:
Insider filing volumes are approaching a seasonal low point due to companies closing trading windows to their insiders until quarterly earnings are released. As a result, the dollar values of trades featured in our Daily Round Up articles (particularly the purchases) will likely be lower than usual until early November.

On Today’s Tables:

Insider trades were rated Significant at :

Hyster-Yale Materials Handling (NYSE:HY); BlackRock Debt Strategy Fund (NYSE:DSU); Community Health Systems (NYSE:CYH); BJ’s Restaurants (NASDAQ:BJRI), and; Natus Medical (NASDAQ:BABY).

Insider trades were rated Nearly Significant at:

Best Medical Stocks To Invest In Right Now: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Novocure Ltd (NASDAQ: NVCR) shares shot up 22 percent to $7.27 after the company posted a narrower-than-expected Q3 loss.

    Shares of TriNet Group Inc (NYSE: TNET) got a boost, shooting up 15 percent to $20.43. TriNet reported Q3 earnings of $0.29 per share on revenue of $770.5 million.

  • [By Chris Lange]

    NocoCure Ltd. (NASDAQ: NVCR) is scheduled to release its fourth-quarter earnings report on February 22 as well. The consensus estimates call for a net loss of $0.11 per share and $53.52 million in revenue. The same period of last year had a net loss of $0.26 per share and $30.24 million in revenue. Shares of Novocure most recently closed at $21.50, with a consensus price target of $27.00 and a 52-week range of $6.75 to $24.15.

Best Medical Stocks To Invest In Right Now: Koppers Holdings Inc.(KOP)

Advisors’ Opinion:

  • [By Monica Gerson]

    Koppers Holdings Inc. (NYSE: KOP) is estimated to report its quarterly earnings at $0.09 per share on revenue of $364.50 million.

    DENTSPLY SIRONA Inc (NASDAQ: XRAY) is expected to report its quarterly earnings at $0.63 per share on revenue of $734.75 million.

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Albemarle Corporation (NYSE: ALB): Free Stock Analysis Report
     
    Celanese Corporation (NYSE: CE): Free Stock Analysis Report
     
    Kronos Worldwide Inc (NYSE: KRO): Free Stock Analysis Report
     
    Koppers Holdings Inc. (NYSE: KOP): Free Stock Analysis Report
     
    Chemours Company (The) (CC): Free Stock Analysis Report
     
    Kraton Corporation (NYSE: KRA): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

Best Medical Stocks To Invest In Right Now: Shutterfly Inc.(SFLY)

Advisors’ Opinion:

  • [By Chris Lange]

    When Shutterfly Inc. (NASDAQ: SFLY) released its fourth-quarter earnings report after the markets closed on Wednesday, the company said it had $2.63 in earnings per share (EPS) and $561.2 million in revenue. The consensus estimates had called for $2.84 in EPS and revenue of $586.4 million. In the same period of last year, it posted EPS of $3.57 and $548.1 million in revenue.

Best Medical Stocks To Invest In Right Now: ePlus Inc.(PLUS)

Advisors’ Opinion:

  • [By Monica Gerson]

    ePlus Inc. (NASDAQ: PLUS) is estimated to post its quarterly earnings at $1.21 per share on revenue of $284.62 million.

    Tilly’s Inc (NYSE: TLYS) is expected to post a quarterly loss at $0.07 per share on revenue of $119.93 million.

Best Medical Stocks To Invest In Right Now: Canadian Pacific Railway Limited(CP)

Advisors’ Opinion:

  • [By Rich Duprey]

    Railroad operator CSX may not have risen as sharply as Alcoa over the past few months, but it has also been steadily rising. It got a big boost this month when the CEO of Canadian Pacific Railway (NYSE:CP) Hunter Harrison resigned his position and was said to be teaming up with activist investor Paul Hilal to take on CSX, causing the railroad’s stock to surge 23% on the news.

  • [By Ben Levisohn]

    A strange turn of events has sent shares of CSX (CSX)–and other railroads, including Union Pacific (UNP) and Canadian Pacific Railway (CP)–soaring today. It all started when Hunter Harrison announced that he would leave Canadian Pacific ahead of schedule to team up with activist investor for the turnaround of another railway company. That company is thought to be CSX.

Best Medical Stocks To Invest In Right Now: International Lithium Corp. (ILHMF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    International Lithium [TSXV:ILC] (OTCPK:ILHMF) – Price = CAD 0.13

    International Lithium (ILC) is a small lithium explorer/project generator with four joint venture lithium projects, and one fully-owned lithium project:

Best Dividend Stocks To Watch For 2018

Bhavik Narsana & Ashraya Rao

For foreign investors looking to invest under the foreign direct investment (FDI) route in India, many questions persist. A significant amount of advice is sought on the nature of the investment instrument through which they should invest. Since the Consolidated FDI Policy (FDI Policy) and Schedule I of the Foreign Exchange Management (Transfer of Security by a Person Resident outside India) Regulations 1999 (FEMA 20) permit only a few investment instruments (being equity shares, compulsorily convertible preference shares (CCPS), warrants and compulsorily convertible debentures (CCDs)) under the FDI route, it becomes important to analyse the benefits of each instrument for the nature of investment sought. The benefits and shortfalls of each of these instruments have to be understood from a corporate and taxation perspective, such that the commercial teams of the foreign investor are duly prepared when sharing their proposal with Indian counterparts. Private limited companies offer more flexibility to structure the investment instruments as compared to public limited companies. Between equity shares and CCPS in private limited companies, financial investors tend to prefer the latter for the flexibility it offers, especially with respect to terms and adjustments for future events, priority for dividends and liquidation events.

Dividends, being freely repatriable, form a significant source of revenue for foreign investors. This article seeks to set out few suggestions with respect to dividends sought by foreign investors from private limited companies while highlighting key issues from a corporate law and foreign exchange law perspective.

Best Dividend Stocks To Watch For 2018: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Novocure Ltd (NASDAQ: NVCR) shares shot up 22 percent to $7.27 after the company posted a narrower-than-expected Q3 loss.

    Shares of TriNet Group Inc (NYSE: TNET) got a boost, shooting up 15 percent to $20.43. TriNet reported Q3 earnings of $0.29 per share on revenue of $770.5 million.

Best Dividend Stocks To Watch For 2018: Google Inc.(GOOG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) reported stronger-than-expected results for its fourth quarter on Monday.

    Alphabet reported a huge Q4 earnings beat of $8.67; consensus estimate called for earnings of $8.10 per share. The company also beat on revenue, coming in at $21.34 billion versus $20.76 billion estimates.

  • [By Ben Levisohn]

    Yes, Chipotle is having a great run. It’s gained 27% so far this year, and traded a new 52-week high today. But Chipotle is also expensive–so expensive that the market appears to be treating it like another Amazon.com (AMZN), Tesla (TSLA), Apple (AAPL), or Alphabet (GOOG), Moas wrote in his downgrade today. He explains:

  • [By Shudeep Chandrasekhar]

    Of the top four tech companies in the world (by market cap), Apple sells the most, earns the most and has the highest operating margins of them all, yet still trades extremely close to Amazon.com (NSDQ:AMZN), the retail giant that operates with wafer thin margins, in terms of price to sales ratio. Even from a price to earnings multiple point of view, Apple commands a much lower valuation than Alphabet Inc(NSDQ:GOOG). What is really surprising is that the company is selling at half the P/S of Microsoft (NSDQ:MSFT), a company that is still on a recovery path. (See also:Apple Inc. Cuts iPhone Production, Time To Sell AAPL Stock?)

  • [By Adam Levine-Weinberg]

    Last week, Brand Finance came out with its annual listing of brand valuations. In a somewhat shocking finding, the consulting group declared that Apple (NASDAQ:AAPL) had lost its supremacy to Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) subsidiary Google.

  • [By Elizabeth Balboa]

    Discontent to serve terrorist agenda as propaganda and recruitment platforms, Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL)’s YouTube, Facebook Inc (NASDAQ: FB) and other online communications companies have committed to heightened site censorship. Over the last two months alone, Facebook reportedly deleted about 66,000 posts flagged as hate speech each week.

Best Dividend Stocks To Watch For 2018: Wendy’s/Arby’s Group Inc.(WEN)

Advisors’ Opinion:

  • [By Jim Jubak, Senior Markets Editor, MoneyShow.com]

    It’s hard for any company to raise prices in the current non-inflationary environment. But it’s especially hard right now for operators of fast food restaurants, given the intense price competition in a very crowded marketplace. McDonald’s sales growth in recent quarters has been driven by the success of its Dollar Menu, so raising prices in that segment are a big deal for the company. In addition, pushback from franchisees who say they can’t afford to refurbish their stores, given higher charges from McDonald’s hits at one of McDonald’s key advantages in its market—it’s ability to refresh stores more frequently than competitors. A McDonald’s refresh at $600,000 on average, according to the company, costs substantially more than a remodel at Burger King (BKW) at $300,000 or Wendy’s (WEN) at $375,000 for the least expensive version. McDonald’s restaurants average $2.5 million in annual sales.

  • [By Stark Merrifield]

    Bill Ackman: Fifty-year-old Ackmans career began in 1992 when he and fellow Harvard graduate David P. Berkowtiz founded the investment firm Gotham Partners. The firms high-profile bid for Rockefeller Center in New York caused investors to flock to the firm, growing it to $500 million in assets. Then in 2004, with $54 million in personal funding, Ackman started Pershing Square Capital Management. Through Pershing, Ackman bought significant shares in companies like Wendys Co. (Nasdaq: WEN), Target Corp. (NYSE: TGT), Chipotle Mexican Grill Inc. (NYSE: CMG), and Valeant Pharmaceuticals International Inc. (NYSE: VRX). Today, Ackman is worth $1.4 billion and is No. 256 on the Forbes 400.

  • [By Michael Flannelly]

    KeyBanc analysts upgraded fast food restaurant operator The Wendy’s Co (WEN) on Friday, noting that the company has a number of positive developments that could provide a floor for the stock.

    The analysts upgraded WEN from “Underweight” to “Hold.”

    KeyBanc analyst Christopher O’Cull said, “We are raising our rating for The Wendy’s Company to HOLD as we believe: 1) Wendy’s SRS performance will diverge from the industry for the foreseeable future as new products are supported by more effective use of marketing dollars; 2) better menu and promotional management will lead to improved franchisee profitability (a focus of the new CFO Todd Penegor); and 3) the opportunity to extend the re-franchising program will provide a floor on the stock.”

    Wendy’s shares were up 7 cents, or 0.81%, during pre-market trading on Friday. The stock is up 57.01% year-to-date.

  • [By Michael Flannelly]

    Argus Research upgraded fast food restaurant operator The Wendy’s Co (WEN) on Thursday, noting that the company’s store remodeling and new menus should help drive higher sales.

    The analysts upgraded WEN from “Hold” to “Buy” and see shares reaching $10. This price target suggests a 21% upside to the stock’s Wednesday closing price of $8.25.

    Wendy’s shares were up 24 cents, or 2.91%, during early morning trading on Thursday. The stock is up 54.19% year-to-date.

top cheap stocks to buy now

Congressman Introduces Bill to Delay DOL Fiduciary Rule

5 Brokers Who Crossed FINRA in Q4

FINRAs Top 5 Exam Priorities for 2017

The great migration from bonds into stocks that many market strategists have been forecasting for 2017 is equivalent to the “fake news” that spread during the presidential campaign, according to Goldman Sachs strategists.

“The political rotation occurring in Washington, D.C….[which] has prompted investors to focus on prospective tax and regulatory reforms after years of partisan gridlock … will not be mirrored in financial portfolios,” write Goldman strategists in their weekly “Kickstart” report. “Despite the sharp fall in bond values during the past six months and the prospect of further losses in 2017, we expect minimal asset rotation away from debt.”

For mutual fund portfolios the bond weighting is much higher – at 30% of total mutual fund assets, but that is in line with 5-year, 10-year and 25-year averages, according to Goldman. Mutual funds could be a source of “incremental demand for equities” as they reduce bond allocations, but the pace will be limited, write Goldman strategists. They expect mutual funds and pension funds will be net sellers of stocks in 2017 while ETFs and foreign investors are net buyers.

top cheap stocks to buy now: United Natural Foods, Inc.(UNFI)

Advisors’ Opinion:

  • [By Peter Graham]

    The Q1 2017 earnings report for small cap natural andorganic foods stock United Natural Foods, Inc (NASDAQ: UNFI) is scheduled for after the market closes onWednesday (December 7th). Shares tend to move in tandeem with Whole Foods Market, Inc (NASDAQ: WFM) who accounts for more than 30% of sales and were falling in September on concerns about WFM’s weakness with Wolfe Research’s Scott Mushkin commenting:

  • [By Peter Graham]

    The Q2 2017 earnings report for small cap natural andorganic foods stock United Natural Foods, Inc (NASDAQ: UNFI) is scheduled for after the market closes onWednesday (March 8th). United Natural Foods shares will tend to move in tandem with Whole Foods Market, Inc (NASDAQ: WFM) who accounts for more than 30% of sales.

  • [By Peter Graham]

    Small cap natural andorganic foods stock United Natural Foods, Inc (NASDAQ: UNFI) reported fiscal Q4 2017 earnings after the Wednesday market close with shares closing up 5.29% after better-than-expected earnings results in a space thats facing deflation especially after the Amazon-Wholefoods deal was announced. Q4 net sales increased 5.7% to $2.34 billion as sales were positively impacted by the acquisitions of Haddon House Food Products, Inc. and Gourmet Guru, Inc (Due to the integration of these acquisitions, the financial impact of acquired businesses is no longer fully separable). Net income increased 12.1% to $38.9 million.

  • [By Peter Graham]

    A long term performance chart for the Hain Celestial Group shows shares having once outperformed underperforming peers such as large capWhole Foods Market, Inc (NASDAQ: WFM) and small cap United Natural Foods, Inc (NASDAQ: UNFI):

top cheap stocks to buy now: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Novocure Ltd (NASDAQ: NVCR) shares shot up 22 percent to $7.27 after the company posted a narrower-than-expected Q3 loss.

    Shares of TriNet Group Inc (NYSE: TNET) got a boost, shooting up 15 percent to $20.43. TriNet reported Q3 earnings of $0.29 per share on revenue of $770.5 million.

top cheap stocks to buy now: Netease.com Inc.(NTES)

Advisors’ Opinion:

  • [By Sreekanth Anasa]

    Shares of Hangzhou, China-based NetEase Inc (NASDAQ:NTES)popped 14% in the Feb 16th trading session after the company reported stellar Q4 and full-year 2016 earnings on Feb 15th after market close. The Chinese online gaming giant delivered an EPS of $4.30 on revenues of $1.74B beating EPS estimates by $0.86 and revenue estimates by $16oM. NetEase’s revenue grew by an impressive 53.1% YoY for Q4 and 67.7% for the full year 2016. On the back of these strong numbers, NTES stock closed at an all-time high of $298.73 in yesterday’s trading session. NTES stock might have gone up very high too soon. There could be a correction around the corner but still NTES stock is a great long-term proposition with much more upside left. Here’s why.

  • [By Joe Tenebruso]

    Shares ofNetEase (NASDAQ:NTES)popped 20.1% last month, according to data provided byS&P Global Market Intelligence, as the Chinese internet technology company’s strong fourth-quarter earnings report was applauded by investors.

top cheap stocks to buy now: Beasley Broadcast Group Inc.(BBGI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, the cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Beasley Broadcast Group Inc (NASDAQ: BBGI) and Lee Enterprises, Incorporated (NYSE: LEE).

  • [By Benzinga News Desk]

    Beasley Broadcast Group (NASDAQ: BBGI) and Greater Media have entered into a definitive agreement under which Beasley will acquire all of the outstanding stock of Greater Media for approximately $240 million.

top cheap stocks to buy now: Firsthand Technology Value Fund, Inc.(SVVC)

Advisors’ Opinion:

  • [By Hibah Yousuf]

    Similarly, Twitter is also the biggest holding in the Firsthand Technology Value Fund (SVVC). With just over 1 million shares of the social media platform, Twitter represents nearly 11% of the total portfolio as of mid-year. Shares of Firsthand Technology Value jumped more than 6% Friday.

oil stock

International Lithium [TSXV:ILC] (OTCPK:ILHMF) – Price = CAD 0.13

International Lithium (ILC) is a small lithium explorer/project generator with four joint venture lithium projects, and one fully-owned lithium project:

Mariana lithium brine in Argentina (20% ILC: 80% GFL). ILC can increase to 30% via a 10% back-in right. Jiangxi Ganfeng Lithium (GFL) is committed to US$10m in expenditures at Mariana. This is their flagship project. Avalonia lithium pegmatite in Ireland (45% ILC: 55% GFL). GFL has the option to acquire an additional 24% after spending US$10m, or producing a Feasibility Study [FS]. Mavis Lake and Raleigh lithium pegmatite in Ontario Canada (49% ILC: 51% Pioneer Resources Limited (OTC:PIONF)). 100% of the Forgan Lake pegmatite project in Canada.

Note that Avalon, Mavis Lake, Raleigh, and Forgan Lake also have rare earths. Jiangxi Ganfeng Lithium (SHE:002460) has an 18.1% stake in ILC in addition to the above joint venture partnerships.

The company states: “International Lithium Corp.’s mission is to find, explore and develop projects that have the potential to become world-class lithium, potash and rare metal deposits.” Their business model involves taking on partners that then help pay the majority of the expenses in getting the project to an advanced stage, thereby minimizing investor dilution, and financing risk.

oil stock: Swedish Export Credit Corp (GRU)

Advisors’ Opinion:

  • [By Casey Wilson]

    Investing in commodity-based ETFs (exchange-traded funds) or ETNs (exchange-traded notes) is a great way to gain exposure to a specific commodity, like corn (NYSE Arca: CORN), livestock (NYSE Arca: COW), or grains (NYSE Arca: GRU).

oil stock: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Novocure Ltd (NASDAQ: NVCR) shares shot up 22 percent to $7.27 after the company posted a narrower-than-expected Q3 loss.

    Shares of TriNet Group Inc (NYSE: TNET) got a boost, shooting up 15 percent to $20.43. TriNet reported Q3 earnings of $0.29 per share on revenue of $770.5 million.

oil stock: Retail Properties of America, Inc.(RPAI)

Advisors’ Opinion:

  • [By Ant贸nio Costa]

    Retail Properties of America Inc (NYSE: RPAI) has been in an impressive rebound since the lows of August and the stock price action continues to become Bullish. However, RPAI has run into the downtrend line resistance again and this could lead to a brief period of sideways consolidation or price correction from current levels. On watch.

oil stock: Outerwall Inc.(OUTR)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Netflix at all time highswhile potential performance peer or competitor Amazon.com, Inc (NASDAQ: AMZN) has continueda more steadyrise and small cap Outerwall Inc (NASDAQ: OUTR), which owned the Redbox business,was swallowed up Apollo Global Management, LLC (NYSE: APO) late last year:

  • [By Monica Gerson]

    Outerwall (NASDAQ: OUTR) dipped 19.33% to $45.15 in the pre-market session after the company lowered its forecast for the third quarter and full year.

  • [By Jake L’Ecuyer]

    Equities Trading DOWN
    Shares of Outerwall (NASDAQ: OUTR) were down 16.03 percent to $47.00 after the company lowered its forecast for the third quarter and full year. Werner Enterprises (NASDAQ: WERN) shares tumbled 4.71 percent to $23.26 after the company issued a weak third-quarter profit forecast. Bank of America downgraded the stock from Buy to Neutral. Pandora Media (NYSE: P) down, falling 1.71 percent to $23.58 as the company announced its plans to sell 14 million shares of common stock, including 4 million shares from current stockholders.

  • [By Monica Gerson]

    Shares of Outerwall Inc (NASDAQ: OUTR) surged over 8 percent in Monday’s after-hours trading session following news for investors the company has begun the process of exploring strategic and financial alternatives. Outerwall’s Board also announced the raising of the company’s quarterly dividend from $0.30 to $0.60 per share. Outerwall shares jumped 8.11 percent to $37.18 in the after-hours trading session.

oil stock: MediWound Ltd.(MDWD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Mediwound Ltd (NASDAQ: MDWD) were down 17 percent to $5.03. Mediwound priced its 4,400,000 offering of ordinary shares at $5 per share.

    Aldeyra Therapeutics Inc (NASDAQ: ALDX) was down, falling around 20 percent to $7.30. Aldeyra Therapeutics reported proposed public offering of common stock.